What We Do
We combine our capabilities with those of our partners to:
- Use induced pluripotent stem cells (iPSCs) and iPSC-derived neurons to study the molecular basis of neurological diseases
- Develop new tools and technology in disease modelling and target engagement that will help to identify potential therapies
- Translate newly developed assays onto an automated high-throughput platform that can be integrated with preclinical drug screens
Ìý
C-BIGxEDDU
Watch our video with Nicolas Ferry, from the Clinical Biospecimen Imaging and Genetic Repository (C-BIG), and Taylor Goldsmith from The Neuro's EDDU (Early Drug Discovery Unit) and learn how we are collaborating to accelerate the discovery of new treatments for neurological disorders benefiting patients worldwide.
Ìý